Industry Focus

Tune in for Motley Fool Advisor Karl Thiel’s debut on Industry Focus as our resident biotech expert discusses the advances and challenges of CRISPR gene-editing technology, as well as how investors should be thinking about the space.

Check out more of our content here:




Reach us by Email @

Direct download: 20210922_IF_Wildcard.mp3
Category:Podcast -- posted at: 5:38pm EST